129 related articles for article (PubMed ID: 36847362)
21. Characterization of an Orthotopic Colorectal Cancer Mouse Model and Its Feasibility for Accurate Quantification in Positron Emission Tomography.
Rapic S; Vangestel C; Verhaeghe J; Van den Wyngaert T; Hinz R; Verhoye M; Pauwels P; Staelens S; Stroobants S
Mol Imaging Biol; 2017 Oct; 19(5):762-771. PubMed ID: 28194632
[TBL] [Abstract][Full Text] [Related]
22. A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases.
Jian M; Ren L; He G; Lin Q; Tang W; Chen Y; Chen J; Liu T; Ji M; Wei Y; Chang W; Xu J
J Transl Med; 2020 Jun; 18(1):234. PubMed ID: 32532289
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Different Colorectal Cancer With Liver Metastases Models Using Six Colorectal Cancer Cell Lines.
Xu Y; Zhang L; Wang Q; Zheng M
Pathol Oncol Res; 2020 Oct; 26(4):2177-2183. PubMed ID: 32172478
[TBL] [Abstract][Full Text] [Related]
24. Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma.
Sugase T; Lam BQ; Danielson M; Terai M; Aplin AE; Gutkind JS; Sato T
J Transl Med; 2020 May; 18(1):208. PubMed ID: 32434572
[TBL] [Abstract][Full Text] [Related]
25. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.
Julien S; Merino-Trigo A; Lacroix L; Pocard M; Goéré D; Mariani P; Landron S; Bigot L; Nemati F; Dartigues P; Weiswald LB; Lantuas D; Morgand L; Pham E; Gonin P; Dangles-Marie V; Job B; Dessen P; Bruno A; Pierré A; De Thé H; Soliman H; Nunes M; Lardier G; Calvet L; Demers B; Prévost G; Vrignaud P; Roman-Roman S; Duchamp O; Berthet C
Clin Cancer Res; 2012 Oct; 18(19):5314-28. PubMed ID: 22825584
[TBL] [Abstract][Full Text] [Related]
27. Orthotopic MC-38 Allograft as a Robust Preclinical Model of Colorectal Carcinoma.
Yakou MH; Afshar-Sterle S; Ernst M; Mielke LA
Methods Mol Biol; 2024; 2806():197-207. PubMed ID: 38676804
[TBL] [Abstract][Full Text] [Related]
28. Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer.
Boos SL; Loevenich LP; Vosberg S; Engleitner T; Öllinger R; Kumbrink J; Rokavec M; Michl M; Greif PA; Jung A; Hermeking H; Neumann J; Kirchner T; Rad R; Jung P
Cell Mol Gastroenterol Hepatol; 2022; 13(2):517-540. PubMed ID: 34700030
[TBL] [Abstract][Full Text] [Related]
29. Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver.
Zhang Y; Davis C; Ryan J; Janney C; Peña MM
Clin Exp Metastasis; 2013 Oct; 30(7):903-18. PubMed ID: 23748471
[TBL] [Abstract][Full Text] [Related]
30. A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.
Raheem O; Kulidjian AA; Wu C; Jeong YB; Yamaguchi T; Smith KM; Goff D; Leu H; Morris SR; Cacalano NA; Masuda K; Jamieson CH; Kane CJ; Jamieson CA
J Transl Med; 2011 Oct; 9():185. PubMed ID: 22035283
[TBL] [Abstract][Full Text] [Related]
31. Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma.
Kobayashi H; Gieniec KA; Ng JQ; Goyne J; Lannagan TRM; Thomas EM; Radford G; Wang T; Suzuki N; Ichinose M; Wright JA; Vrbanac L; Burt AD; Takahashi M; Enomoto A; Worthley DL; Woods SL
J Vis Exp; 2021 Sep; (175):. PubMed ID: 34542536
[TBL] [Abstract][Full Text] [Related]
32. The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse model.
Margolin DA; Myers T; Zhang X; Bertoni DM; Reuter BA; Obokhare I; Borgovan T; Grimes C; Green H; Driscoll T; Lee CG; Davis NK; Li L
FASEB J; 2015 Aug; 29(8):3571-81. PubMed ID: 25962655
[TBL] [Abstract][Full Text] [Related]
33. Orthotopic Xenografts of Colorectal Cancer Stem Cells.
De Angelis ML; Francescangeli F; Zeuner A; Baiocchi M
Methods Mol Biol; 2022; 2429():555-565. PubMed ID: 35507189
[TBL] [Abstract][Full Text] [Related]
34. Restoration of PTEN activity decreases metastases in an orthotopic model of colon cancer.
Chowdhury S; Ongchin M; Wan G; Sharratt E; Brattain MG; Rajput A
J Surg Res; 2013 Oct; 184(2):755-60. PubMed ID: 23623571
[TBL] [Abstract][Full Text] [Related]
35. Tumor growth and metastasis of human colorectal cancer cell lines in SCID mice resemble clinical metastatic behaviors.
Yasui N; Sakamoto M; Ochiai A; Ino Y; Akimoto S; Orikasa A; Kitajima M; Hirohashi S
Invasion Metastasis; 1997; 17(5):259-69. PubMed ID: 9876220
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
38. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts.
Lieu CH; Klauck PJ; Henthorn PK; Tentler JJ; Tan AC; Spreafico A; Selby HM; Britt BC; Bagby SM; Arcaroli JJ; Messersmith WA; Pitts TM; Eckhardt SG
Oncotarget; 2015 Oct; 6(33):34561-72. PubMed ID: 26439693
[TBL] [Abstract][Full Text] [Related]
40. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
